Jason Apter
Amministratore Delegato presso Sannova Analytical, Inc.
Profilo
Jason Apter is currently the Chief Executive Officer at Sannova Analytical, Inc. since 2022.
Prior to this, he worked as the Chief Executive-Health Sector at Johnson Matthey Plc from 2018 to 2020.
Posizioni attive di Jason Apter
Società | Posizione | Inizio |
---|---|---|
Sannova Analytical, Inc.
Sannova Analytical, Inc. Miscellaneous Commercial ServicesCommercial Services Sannova Analytical, Inc. is a contract research organization that provides bioanalytical and chemistry manufacturing and controls testing services to biopharmaceutical and biotech companies for both small and large molecules. The company is based in Somerset, NJ and was founded in 2006 by Venkat Reddy, Geeta Vidiyala, and Malleswar Kollu. Sannova is known for its consistently low variability data, quick turnaround times, and over 300 validated methods. The company has completed over 1,200 clinical trials and has maintained an impeccable inspection record with the FDA and its sponsors. Sannova is considered a trusted and quality-focused partner in drug development by customers with a strong track record of regulatory compliance. Jason Apter has been the CEO of the company since 2022. | Amministratore Delegato | 26/10/2022 |
Precedenti posizioni note di Jason Apter
Società | Posizione | Fine |
---|---|---|
JOHNSON MATTHEY PLC | Corporate Officer/Principal | 01/06/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
JOHNSON MATTHEY PLC | Process Industries |
Aziende private | 1 |
---|---|
Sannova Analytical, Inc.
Sannova Analytical, Inc. Miscellaneous Commercial ServicesCommercial Services Sannova Analytical, Inc. is a contract research organization that provides bioanalytical and chemistry manufacturing and controls testing services to biopharmaceutical and biotech companies for both small and large molecules. The company is based in Somerset, NJ and was founded in 2006 by Venkat Reddy, Geeta Vidiyala, and Malleswar Kollu. Sannova is known for its consistently low variability data, quick turnaround times, and over 300 validated methods. The company has completed over 1,200 clinical trials and has maintained an impeccable inspection record with the FDA and its sponsors. Sannova is considered a trusted and quality-focused partner in drug development by customers with a strong track record of regulatory compliance. Jason Apter has been the CEO of the company since 2022. | Commercial Services |
- Borsa valori
- Insiders
- Jason Apter